Kalliokoski Paul, Rodhe Nils, Bergqvist Yngve, Löfvander Monica
Primary Health Care Centre Jakobsgårdarna, Jaxtorget 7A, Box 100 33, S-781 10, Borlänge, Sweden.
Centre for Clinical Research Dalarna, Falun, Sweden.
BMC Pregnancy Childbirth. 2016 Nov 15;16(1):353. doi: 10.1186/s12884-016-1117-3.
Muscular weakness and severe vitamin D deficiency is prevalent in Somali (veiled) pregnant women, Sweden. The study aims here were to explore adherence to prescribed supplemental vitamin D in new mothers with vitamin D deficiency and its effects on grip strength and upper leg performance in Somali (target group TG) and Swedish women (reference group RG) from spring through winter.
A before- and after study was designed. A cross-sectional sample of women in antenatal care with serum 25-OHD ≤50 nmol/L were prescribed one or two tablets daily (800 or 1600 IU vitamin D3 with calcium) for 10 months. Reminders were made by Somali nurses (TG) or Swedish doctors (RG). Baseline and 10 month measurements of plasma nmol/L 25-OHD, maximal grip strength held for 10 s (Newton, N) and ability to squat (yes;no) were done. Total tablet intake (n) was calculated. Outcome variables were changes from baseline in grip strength and ability to squat. Predicting variables for change in grip strength and ability to squat were calculated using linear and binary regression in final models. Undetectable 25-OHD values (<10 nmol/L) were replaced with '9' in statistic calculations.
Seventy-one women (46 TG, 1/3 with undetectable baseline 25-OHD; 25 RG) participated. At the 10-month follow up, 17% TG and 8% RG women reported having refrained from supplement. Mean 25-OHD increased 16 to 49 nmol/L (TG) and 39 nmol/L to 67 nmol/L (RG), (both p < 0.001). Grip strength had improved from 153 to 188 N (TG) (p < 0.001) and from 257 to 297 N (RG) (p = 0.003) and inability to squat had decreased in TG (35 to 9, p < 0.001). Intake of number of tablets predicted increased grip strength (B 0.067, 95%CI 0.008-0.127, p = 0.027). One tablet daily (>300 in total) predicted improved ability to squat (OR 16; 95% CI 1.8-144.6).
Adherence to supplemental vitamin D and calcium should be encouraged as an even moderate intake was associated to improved grip strength and upper leg performance, which was particularly useful for the women with severe 25-OHD deficiency and poor physical performance at baseline.
ClinicalTrials.gov Identifier: NCT02922803 . Date of registration: September 28, 2016.
在瑞典的索马里(蒙面)孕妇中,肌肉无力和严重维生素D缺乏症很普遍。本研究旨在探讨维生素D缺乏的新妈妈对规定补充维生素D的依从性,以及从春季到冬季,这对索马里女性(目标组TG)和瑞典女性(参照组RG)握力和大腿上部运动能力的影响。
设计了一项前后对照研究。对产前护理中血清25-OHD≤50 nmol/L的女性进行横断面抽样,每天开1片或2片药(含800或1600 IU维生素D3及钙),持续10个月。由索马里护士(TG组)或瑞典医生(RG组)进行提醒。在基线和10个月时测量血浆中25-OHD的nmol/L值、保持10秒的最大握力(牛顿,N)以及下蹲能力(是;否)。计算总药片摄入量(n)。结果变量是握力和下蹲能力相对于基线的变化。在最终模型中,使用线性回归和二元回归计算握力和下蹲能力变化的预测变量。在统计计算中,无法检测到的25-OHD值(<10 nmol/L)用“9”代替。
71名女性(46名TG组,其中1/3基线25-OHD无法检测;25名RG组)参与。在10个月的随访中,17%的TG组女性和8%的RG组女性报告未服用补充剂。平均25-OHD从16 nmol/L升至49 nmol/L(TG组),从39 nmol/L升至67 nmol/L(RG组),(两者p<0.001)。握力从153 N提高到188 N(TG组)(p<0.001),从257 N提高到297 N(RG组)(p=0.003),TG组无法下蹲的情况有所减少(从35例降至9例,p<0.001)。药片摄入量可预测握力增加(B 0.067,95%CI 0.008-0.127,p=0.027)。每天服用1片(总共>300片)可预测下蹲能力提高(OR 16;95%CI 1.8-144.6)。
应鼓励坚持补充维生素D和钙,因为即使是适度摄入也与握力和大腿上部运动能力的改善有关,这对基线时25-OHD严重缺乏且身体机能较差的女性尤为有用。
ClinicalTrials.gov标识符:NCT02922803。注册日期:2016年9月28日。